1. Acar JF, O’Bmen TF, Goldstein FW, Jones RN (1993) The epidemiology of bacterial resistance to quinolones. Drugs 45(S3):24–28
2. Alangaden GJ, Manavathu EK, Lerner SA (1994) Activity of ciprofloxacin (Cip), ofloxacin (Oil), sparfloxacin (Spl) and five investigational fluoroquinolones against quinolone-resistant strains of mycobacterium tuberculosis (Mtb) (Abstr 29). 5th International Symposium on New Quinolones, Singapore, 25–27 August 1994
3. Allegra L, Brumpt I (1994) Sparfloxacin (S) in the management of acute exacerbations (AE) of chronic obstructive pulmonary disease (COPD): a comparison with augmentin (AC) (Abstr 139). 5th International Symposium on New Quinolones, Singapore, 25–27 August 1994
4. Al-Sibai MB, Halim MA, El-Shaker MM, Khan BA, Qadri SMH (1992) Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrob Agents Chemother 36:150–152
5. Alvarez M, Velasco P, Unzaga J, Berdonces P, Busto C, Amezua B, Cisterna R (1993) Antibiotic susceptibilities of microorganisms in respiratory tract infection (1988- 1992). Recent advances in chemotherapy. Proceedings of the 18th International Congress of Chemotherapy, Stockholm, 27 June-11 July 1993, pp 322–323